SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | 2026-08-01 | Grant/award | 10694 | $1000K |
| Wattula Andy | EVP OM&R-Ventas/Pres&CEO-LHS | 2026-08-01 | Grant/award | 4314 | $403K |
| Barnes Melody C | Director | 2026-07-16 | Grant/award | 72 | $7K |
| EMBLER MICHAEL J | Director | 2026-07-16 | Grant/award | 72 | $7K |
| LUSTIG MATTHEW J | Director | 2026-07-16 | Grant/award | 210 | $20K |
| LUSTIG MATTHEW J | Director | 2026-07-16 | Grant/award | 72 | $7K |
| Martino Roxanne M | Director | 2026-07-16 | Grant/award | 174 | $17K |
| NADER MARGUERITE M | Director | 2026-07-16 | Grant/award | 72 | $7K |
| Rodriguez Joe Vasquez Jr. | Director | 2026-07-16 | Grant/award | 49 | $5K |
| Roy Sumit | Director | 2026-07-16 | Grant/award | 47 | $4K |
| Roy Sumit | Director | 2026-07-16 | Grant/award | 72 | $7K |
| Smith Maurice S | Director | 2026-07-16 | Grant/award | 56 | $5K |
| Smith Maurice S | Director | 2026-07-16 | Grant/award | 72 | $7K |
| LUSTIG MATTHEW J | Director | 2026-07-01 | Grant/award | 448 | $40K |
| Martino Roxanne M | Director | 2026-07-01 | Grant/award | 544 | $49K |
| Roy Sumit | Director | 2026-07-01 | Grant/award | 349 | $31K |
| Smith Maurice S | Director | 2026-07-01 | Grant/award | 461 | $41K |
| EMBLER MICHAEL J | Director | 2026-06-03 | Open-market buy | 2500 | $197K |
| RAKOWICH WALTER C | Director | 2026-05-14 | Open-market sell 10b5-1 | 1152 | $104K |
| BIGMAN THEODORE | Director | 2026-05-13 | Grant/award | 2047 | $185K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
Risk disclosures broadened and sharpened across debt, macro, regulatory, and operational dimensions, with no meaningful offsets. The most consequential additions are new credit-rating downgrade risk on a leveraged balance sheet and concrete near-term variable-rate exposure tied to actual Fed actions, compounding capital-access concerns already flagged by expanded capital-market risk enumeration. Secondary pressure comes from newly specific geographic demand concentration, tariff and labor cost pass-through risk to tenants, and a fresh AI operational/compliance risk layer.
5 company-specific · 5 common-mode
Added explicit disclosure of consumer spending risk and regional concentration exposure in California, Texas, New York, Quebec, Illinois—material new specificity on geographic and demand vulnerabilities.
Risks Relating to Our Business Operations and Strategy Macroeconomic trends, including trends relating to labor costs, unemployment, inflation, interest rates and exchange rates, may affect our…
Specific NIH indirect cost cap (15%) removed; replaced with vague "substantial policy changes" language. Escalates from example to broader enacted policies affecting research funding and healthcare spending.
Changes in the U.S. political and regulatory environment could affect availability of government funding that we or our managers, tenants or borrowers rely on, which could negatively impact our…
Added explicit risk that changes in manager ownership or leadership could impair property management and compliance, escalating concentration risk beyond prior financial/legal difficulties language.
A significant portion of our revenues and operating income is dependent on a limited number of tenants and managers, including Ardent, Kindred, Atria, Sunrise and Le Groupe Maurice. The portfolios…
New disclosure of broader asset-sale risk: inability to sell properties timely or favorably, funding obligations during sales, and potential value decline—beyond prior year's focus on third-party encumbrances.
We may be unable to sell certain properties on a timely basis or on favorable terms, which may have an adverse effect on our business, financial condition and results of operations. From time to…
Added specific disclosure of actual Fed rate actions and near-term variable-rate exposure risks, escalating from generic interest rate risk to concrete current threat.
We are exposed to increases in interest rates, which could reduce our profitability and adversely impact our ability to refinance existing debt, sell assets or engage in acquisition, investment…
New disclosure of credit rating risk and potential downgrade consequences. Addresses material financing costs, covenant restrictions, and capital access—substantive concerns for a leveraged entity.
Adverse changes in our credit ratings could impair our ability to obtain additional debt and equity financing on favorable terms. Our credit ratings affect the amount and type of capital, as well as…
Added specific tariff and rising labor cost risks, escalating from generic macroeconomic language to concrete cost pressures affecting tenants and borrowers.
We may face increased risks and costs associated with volatility in materials and labor prices or as a result of supply chain or procurement disruptions, which may adversely affect the status of our…
New disclosure of AI implementation risks: operational failures, regulatory exposure, competitive disadvantage, cybersecurity threats, and reputational harm. Substantive operational and compliance risk.
The use of, or inability to take advantage of the benefits of, artificial intelligence by us or our managers, tenants and borrowers presents risks and challenges that may adversely impact our…
Expanded disclosure of specific capital market risks: added bullet-point enumeration of market conditions (pandemics, inflation, recessions, unemployment, tightening labor markets) and cross-references to related risk factors, signaling heightened concern about capital access constraints.
Risks Relating to Our Capital Structure Market conditions, the actual and perceived state of the capital markets generally and limitations on our ability to access such markets could negatively…
New disclosure of climate regulation risk requiring capital expenditures without guaranteed revenue offset—a substantive operational and financial burden.
We and our managers, tenants and borrowers may be adversely affected by regulation and enforcement. 40 Table of Contents We and our managers, tenants and borrowers are subject to or impacted by…
Ventas issued a press release on July 29, 2026 announcing its results of operations for the quarter ended June 30, 2026, disclosing per-share metrics (Attributable Net Income of $0.14, Normalized FFO of $0.97), year-over-year growth figures (17% NOI growth, 10% Same-Store Cash NOI growth), and raising full-year 2026 earnings guidance. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary, notified Ventas of her intention to resign effective June 26, 2026.
View raw filing on EDGAR →Kevin M. Bohl is assuming the responsibilities of General Counsel, Ethics & Compliance Officer and Corporate Secretary on an interim basis, expanding his executive role from Senior Vice President, Deputy General Counsel and Assistant Corporate Secretary.
View raw filing on EDGAR →